According to a new report, published by KBV research, The Global Nutrigenomics Market size is expected to reach $1.45 billion by 2030, rising at a market growth of 16.6% CAGR during the forecast period.
Integrating wearable devices and health trackers into nutrigenomics is a notable innovation. Combining genetic data with real-time health metrics obtained from wearables allows for dynamic adjustments to personalized nutrition plans. This approach leverages ongoing health monitoring to refine dietary recommendations based on immediate physiological responses. The synergy of wearable devices and nutrigenomics allows for creating dynamic and adaptive personalized nutrition plans. Traditional dietary recommendations often remain static, but with real-time health monitoring, adjustments can be made on the fly. For example, if wearables detect increased physical activity or changes in sleep patterns, the nutrigenomic algorithm can dynamically modify the dietary advice to align with the immediate needs of the individual.
Moreover, AI-driven meal planning platforms are emerging as innovative tools in the nutrigenomics space. These platforms leverage genetic data to generate personalized meal plans that align with an individual's genetic predispositions. The integration of AI streamlines the process of developing customized nutrition strategies and adapts recommendations over time based on user feedback and evolving health data.
The Services segment is experiencing a CAGR of 17.3% during (2023 - 2030). The shift towards preventive healthcare has been a driving force behind the growth of nutrigenomic services. With a focus on disease prevention and health optimization, individuals are turning to nutrigenomics to gain insights into their genetic predispositions and make informed lifestyle and dietary choices. Nutrigenomic services are crucial in empowering individuals to manage their health proactively. Therefore, the segment will expand rapidly in the coming years.
The Hospitals & Clinics segment is leading the Global Nutrigenomics Market by End User in 2022; thereby, achieving a market value of $981.7 Million by 2030. Growing awareness among healthcare professionals and patients about the potential benefits of nutrigenomics has driven demand for these services within hospital and clinic settings. Patients are becoming more proactive about their health, seeking personalized approaches to nutrition that can be seamlessly integrated into their overall healthcare plans. As a result, there will be increased demand in the segment.
The Diabetes segment is registering a CAGR of 16.9% during (2023 - 2030). Nutrigenomics involves studying how individual genetic variations impact responses to nutrients. In diabetes, personalized nutrition plans tailored to an individual's genetic profile can be crucial in managing blood sugar levels. These tailored plans may consider genetic factors related to insulin sensitivity, glucose metabolism, and other diabetes-related aspects. These aspects will play a significant role in the expansion of the segment.
Full Report: https://www.kbvresearch.com/nutrigenomics-market/
The North America region dominated the Global Nutrigenomics Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $503.6 Million by 2030. The Europe region is anticipated to grow a CAGR of 16.4% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 17.4% during (2023 - 2030).
By Product
By End User
By Application
By Geography
Unique Offerings 
